Tideglusib

Tideglusib
Trade Name
Orphan Indication Myotonic Dystrophy 1
USA Market Approval USA
USA Designation Date 2017-06-19 00:00:00
Sponsor AMO Pharma Ltd.;Throwsters, The Street;Wonersh